Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GMNN | O75496 | 1/20 | 0.59 |
| ▸ | TP53 | P04637 | 1/20 | 0.59 |
| ▸ | POLB | P06746 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
| ▸ | THRB | P10828 | 1/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.59 |
| ▸ | BLM | P54132 | 1/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.50 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | BHMT | Q93088 | 1/20 | 0.39 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | CES1 | P23141 | 1/20 | 0.36 |
| ▸ | MMP12 | P39900 | 1/20 | 0.36 |
| ▸ | MMP13 | P45452 | 1/20 | 0.36 |
| ▸ | MVD | P53602 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15282760 | 0.87 | HSD17B10 (0.65) | GMNNTP53POLBMAPTTHRB | |
| SCHEMBL9787576 | 0.85 | — | — | |
| SCHEMBL31074291 | 0.83 | CYP2D6 (0.52) | GMNNTP53POLBMAPTTHRB | |
| SCHEMBL31074329 | 0.83 | CYP2D6 (0.52) | GMNNTP53POLBMAPTTHRB | |
| SCHEMBL31074314 | 0.83 | CYP2D6 (0.52) | GMNNTP53POLBMAPTTHRB | |
| SCHEMBL31074290 | 0.83 | CYP2D6 (0.52) | GMNNTP53POLBMAPTTHRB | |
| SCHEMBL31074318 | 0.83 | CYP2D6 (0.52) | GMNNTP53POLBMAPTTHRB | |
| SCHEMBL31074277 | 0.83 | CYP2D6 (0.52) | GMNNTP53POLBMAPTTHRB | |
| SCHEMBL31074302 | 0.83 | CYP2D6 (0.52) | GMNNTP53POLBMAPTTHRB | |
| SCHEMBL31074315 | 0.83 | CYP2D6 (0.52) | GMNNTP53POLBMAPTTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3083911-B1 | MICHAEL SYSTEMS FOR ODOR STABILIZATION | HENKEL AG & CO KGAA (DE) | 2018-03-21 | — | — | EP | claimed |
| US-10920176-B2 | Transparent liquids, in particular fabric treatment agents, comprising perfume and microcapsules with an odor modulator compound | HENKEL AG & CO. KGAA (DE) | 2021-02-16 | — | — | US | disclosed |
| US-20180201883-A1 | TRANSPARENT LIQUIDS, IN PARTICULAR FABRIC TREATMENT AGENTS, COMPRISING PERFUME AND MICROCAPSULES WITH AN ODOR MODULATOR COMPOUND | HENKEL AG & CO. KGAA (DE) | 2018-07-19 | — | — | US | disclosed |
| EP-3083911-B1 | MICHAEL SYSTEMS FOR ODOR STABILIZATION | HENKEL AG & CO KGAA (DE) | 2018-03-21 | — | — | EP | disclosed |
| EP-3083911-A1 | MICHAEL SYSTEMS FOR ODOR STABILIZATION | Henkel AG & Co. KGaA (DE) | 2016-10-26 | — | — | EP | disclosed |
| US-20160096817-A1 | TREATMENT OF INFLAMMATORY BOWEL DISEASE | ALLERGAN, INC. | 2016-04-07 | — | — | US | disclosed |
| WO-2015091054-A1 | MICHAEL SYSTEMS FOR ODOR STABILIZATION | HENKEL AG & CO. KGAA (DE) | 2015-06-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160096817-A1 | TREATMENT OF INFLAMMATORY BOWEL DISEASE | SLC10A2, FABP2, LTB4R2 | GMNN 3125/4885TP53 4539/4885POLB 1242/4885 |
| US-10920176-B2 | Transparent liquids, in particular fabric treatment agents, comprising perfume and microcapsules with an odor modulator compound | NEFM, TRPA1, ALOX5 | GMNN 706/4885TP53 873/4885POLB 1941/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.